v3.22.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]        
Research and development $ 915,363 $ 273,038 $ 1,843,397 $ 463,306
General and administrative 964,281 279,093 2,662,293 665,742
Total operating expenses 1,879,644 552,131 4,505,690 1,129,048
Loss from operations (1,879,644) (552,131) (4,505,690) (1,129,048)
Other income (expenses), net 3,153 (3,701) 2,813 (11,767)
Net loss (1,876,491) (555,832) (4,502,877) (1,140,815)
Deemed dividends (8,208,393) (8,208,393)
Net loss attributable to common stockholders $ (1,876,491) $ (8,764,225) $ (4,502,877) $ (9,349,208)
Weighted average common shares outstanding, basic and diluted 23,344,567 12,982,500 23,344,567 12,656,310
Net loss per share, basic and diluted $ (0.08) $ (0.68) $ (0.19) $ (0.74)

Source